Bivalirudin for left ventricular assist device thrombosis
This study analyzes the largest cohort to date of LVAD p atients with pump thrombosis treated with bivalirudin therapy, and suggests that alternative therapies should be considered in management.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Alternative and Complementary Therapies | Angiomax | Complementary Medicine | Hematology | Hospitals | Study | Thrombosis